{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T02:55:25Z","timestamp":1768445725497,"version":"3.49.0"},"update-to":[{"DOI":"10.1002\/14651858.cd000030","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2004,10,18]],"date-time":"2004-10-18T00:00:00Z","timestamp":1098057600000}}],"reference-count":63,"publisher":"Wiley","issue":"2","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd000030.pub2","type":"journal-article","created":{"date-parts":[[2004,10,14]],"date-time":"2004-10-14T07:10:33Z","timestamp":1097737833000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Antipsychotic medication versus placebo for people with both schizophrenia and learning disability"],"prefix":"10.1002","volume":"2013","author":[{"given":"Lorna","family":"Duggan","sequence":"first","affiliation":[{"name":"Kneeswork House Hosptial; Partnership in Care Bassingbourn Herts UK SG8 5JP"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Brylewski","sequence":"additional","affiliation":[{"name":"Oxford UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,10,18]]},"reference":[{"key":"10.1002\/14651858.CD000030.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/070674377201700209","article-title":"Propericiazine in psychiatric emergencies. A controlled comparative study","volume":"17","author":"Ananth","year":"1972","journal-title":"Canadian Psychiatric Association Journal"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0002|cit2","first-page":"967","article-title":"No English title available","volume":"20","author":"Angst","year":"1970","journal-title":"Arzneimittelforschung"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000118075","article-title":"Pharmacotherapy of agitational states in psychiatric gerontology: double-blind study: febarbamat-pipamperon","volume":"11","author":"Brenner","year":"1984","journal-title":"Neuropsychobiology"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0004|cit4","first-page":"440","article-title":"The use of clozapine in a mentally retarded and aggressive population","volume":"55","author":"Cohen","year":"1994","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000118170","article-title":"The effect of milenperone on the agressive behavior of oligophrenic patients: a double-blind placebo-controlled study","volume":"13","author":"Cuyper","year":"1985","journal-title":"Neuropsychobiology"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0006|cit6","first-page":"71","article-title":"No English title available","volume":"34","author":"Guzman","year":"1971","journal-title":"Archivos de Neurobiologia"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1177\/009127006600600608","article-title":"Lack of addiction from high doses of tybamate","volume":"6","author":"Feldman","year":"1966","journal-title":"Journal of New Drugs"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1192\/bjp.104.434.201","article-title":"Combined chlorpromazine and reserpine in the treatment of chronic psychotics","volume":"104","author":"Foote","year":"1958","journal-title":"Journal of Mental Science"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0009|cit9","first-page":"302","article-title":"No English title available","volume":"22","author":"Fracassi","year":"1976","journal-title":"Acta Psiquiatrica y Psicologica de America Latina"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/00005053-198911000-00005","article-title":"Multiple versus single antipsychotic drug treatment in chronic psychosis","volume":"177","author":"Godleski","year":"1989","journal-title":"Journal of Nervous Mental Disease"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0011|cit11","first-page":"5","article-title":"Cis(Z)-clopenthixol - the neuroleptically active isomer of clopenthixol: a presentation of five double-blind clinical investigations and other studies with cis(Z)-clopenthixol (Cisordinol, Clopixol)","volume":"294","author":"Gravem","year":"1981","journal-title":"Acta Psychiatrica Scandinavica Supplementum"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0012|cit12","first-page":"25","article-title":"A double-blind clinical investigation of cis(Z)-clopenthixol and clopenthixol in chronic schizophrenic patients","volume":"294","author":"Heikkila","year":"1981","journal-title":"Acta Psychiatrica Scandinavica Supplementum"},{"issue":"1","key":"10.1002\/14651858.CD000030.pub2-BIB0013|cit13","first-page":"131","article-title":"Mesoridazine (TPS 23 Sandoz) in acute psychotic states","volume":"112","author":"Jost","year":"1973","journal-title":"Schweizer Archiv fur Neurologie, Neurochirurgie und Psychiatrie"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0014|cit14","first-page":"39","article-title":"Neuroleptic treatment of oligophrenic patients. A double-blind multicentre trial of cis(z)-clopenthixol and haloperidol","volume":"294","author":"Karsten","year":"1981","journal-title":"Acta Psychiatrica Scandinavica Supplementum"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF00408335","article-title":"No English title available","volume":"9","author":"Kuhn","year":"1966","journal-title":"Psychopharmacologia"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0016|cit16","first-page":"177","article-title":"No English title available","volume":"13","author":"Kumpel","year":"1971","journal-title":"Activitas Nervosa Superior"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1192\/bjp.112.482.95","article-title":"A controlled trial of prothipendyl (tolnate) in mentally subnormal patients","volume":"112","author":"McKenzie","year":"1966","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0018|cit18","first-page":"316","article-title":"Diagnosis and pharmacotherapy of schizophrenia in the retarded","volume":"21","author":"Menolascino","year":"1985","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3109\/08039486709094598","article-title":"No English title available","volume":"21","author":"Nielsen","year":"1967","journal-title":"Nordisk Psykiatrisk Tidsskrift"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0020|cit20","first-page":"168","article-title":"Clinical experience with carpipramine (Defekton)","volume":"16","author":"Pislova","year":"1974","journal-title":"Activitas Nervosa Superior"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0010-440X(94)90166-X","article-title":"The use of clozapine in borderline intellectual functioning and mentally retarded schizophrenic patients","volume":"35","author":"Sajatovic","year":"1994","journal-title":"Comprehensive Psychiatry"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1177\/106002809202601114","article-title":"Nonneuroleptic treatment of disruptive behavior in organic mental syndromes","volume":"26","author":"Smith","year":"1992","journal-title":"Annals of Pharmacotherapy"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0023|cit23","first-page":"483","article-title":"The effect of a protriptyline-perphenazine combination in chronic psychiatric patients","volume":"8","author":"St-Jean","year":"1966","journal-title":"Current Therapeutic Research Clinical and Experimental"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0140-6736(93)92660-L","article-title":"Eltoprazine for aggression in schizophrenia and mental retardation","volume":"341","author":"Tiihonen","year":"1993","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0025|cit25","first-page":"737","article-title":"Loxapine succinate in the treatment of uncontrollable destructive behavior","volume":"13","author":"Varga","year":"1971","journal-title":"Current Therapeutic Research Clinical Experimental"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/030006058000800104","article-title":"Loxapine versus thioridazine in the treatment of organic psychosis","volume":"8","author":"Versiani","year":"1980","journal-title":"Journal of International Medical Research"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1600-0447.1971.tb02219.x","article-title":"Clinical evaluation of the long-acting injectable neuroleptic, fluspirilene, in the treatment of schizophrenic and mentally retarded patients","volume":"47","author":"Zwanikken","year":"1971","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0028|cit28","first-page":"83","article-title":"Penfluridol ( R16341). A long-acting oral neuroleptic, as maintenance therapy for schizophrenic and mentally retarded patients. A placebo-controlled double-blind trial","volume":"76","author":"Zwanikken","year":"1973","journal-title":"Psychiatria, Neurologia, Neurochirugia"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0029|cit29","unstructured":"Alderson M Green S Higgins JPT editors Cochrane Reviewers' Handbook 4.4.2. [updated March 2004] The Cochrane Library 2004"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0031|cit31","article-title":"Drugs and learning in mentally retarded persons","volume-title":"Advances in human psychopharmacology","author":"Aman","year":"1984"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0032|cit32","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)","author":"American Psychiatric Association","year":"1994"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bmj.315.7108.600","article-title":"Statistics notes. Trials randomised in clusters","volume":"315","author":"Bland","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0034|cit34","volume-title":"British National Formulary","author":"British Medical Association and Royal Pharmaceutical Society of Great Britain","year":"2004"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0035|cit35","first-page":"385","article-title":"Psychotropic drugs and mental retardation: I. Disabilities and the prescription of drugs for behaviour and for epilepsy in three residential settings","volume":"34","author":"Clarke","year":"1990","journal-title":"Journal of Mental Deficiency Research"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0036|cit36","first-page":"11","article-title":"Psychiatric morbidity and mental retardation","volume-title":"Psychiatric illness and mental handicap","author":"Corbett","year":"1979"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF02599201","article-title":"The unit of analysis error in studies about physicians' patient care behavior","volume":"7","author":"Divine","year":"1992","journal-title":"Journal of General Internal Medicine"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1002\/sim.1301","article-title":"Issues in the meta-analysis of cluster randomized trials","volume":"21","author":"Donner","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1176\/ajp.139.10.1297","article-title":"Psychiatric disorders in the mentally retarded: types, problems and challenges","volume":"139","author":"Eaton","year":"1982","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1192\/bjp.149.1.68","article-title":"Psychiatric disorders in mildly and severely mentally retarded urban children and adolescents: epidemiological aspects","volume":"49","author":"Gillberg","year":"1986","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2788.1994.tb00347.x","article-title":"A controlled community study of movement disorder in people with learning difficulties on antipsychotic medication","volume":"37","author":"Gingell","year":"1994","journal-title":"Journal of Intellectual Disability Research"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/oxfordjournals.aje.a009904","article-title":"Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994","volume":"149","author":"Gulliford","year":"1999","journal-title":"American Journal of Epidemiology"},{"issue":"3","key":"10.1002\/14651858.CD000030.pub2-BIB0043|cit43","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002317","article-title":"Tricyclic drugs for depression in children and adolescents","author":"Hazell","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1192\/bjp.130.6.525","article-title":"Psychosis in mental handicap","volume":"130","author":"Heaton-Ward","year":"1977","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/schbul\/12.1.52","article-title":"Epidemiology of schizophrenia: a European perspective","volume":"12","author":"Jablensky","year":"1986","journal-title":"Schizophrenia Bulletin"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0047|cit47","first-page":"307","article-title":"Secret US report surfaces on antidepressants in children.","volume":"329","author":"Lenzer","year":"2004","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1600-0447.1985.tb02655.x","article-title":"The prevalence of psychiatric morbidity in mentally retarded adults","volume":"72","author":"Lund","year":"1985","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1192\/bjp.176.3.249","article-title":"Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia","volume":"176","author":"Marshall","year":"2000","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1126\/science.304.5677.1576","article-title":"Antidepressants and children. Buried data can be hazardous to a company's health","volume":"304","author":"Marshall","year":"2004","journal-title":"Science"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1037\/0022-006X.62.1.6","article-title":"Theories of dual diagnosis in mental retardation","volume":"62","author":"Matson","year":"1994","journal-title":"Journal of Consulting and Clinical Psychology"},{"issue":"15","key":"10.1002\/14651858.CD000030.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1001\/jama.285.15.1987","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials","volume":"285","author":"Moher","year":"2001","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0053|cit53","article-title":"Guidance on the use of newer (atypical) antipsychotic drugs for the treatment of schizophrenia","volume-title":"Technology Appriasal - No 43","author":"National Institute for Clinical Excellence","year":"2002"},{"issue":"3","key":"10.1002\/14651858.CD000030.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/00001756-200303030-00042","article-title":"Do atypical antipsychotics fail to exert cognitive sparing effects?","volume":"14","author":"Papageorgiou","year":"2003","journal-title":"Neuroreport"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0055|cit55","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4684-4742-2_1","article-title":"The nature and incidence of mental illness in mentally retarded individuals","volume-title":"Handbook of mental illness in the mentally retarded","author":"Parson","year":"1984"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1192\/bjp.158.1.97","article-title":"The motor disorders of mental handicap. An overlap with the motor disorders of severe psychiatric illness","volume":"158","author":"Rogers","year":"1991","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0057|cit57","first-page":"35","article-title":"A neuropsychiatric study in childhood","volume-title":"Clinics in developmental medicine","author":"Rutter","year":"1970"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1177\/000486749202600208","article-title":"Drug induced movement disorders in institutionalised adults with mental retardation. Clinical characteristics and risk factors","volume":"26","author":"Sachdev","year":"1992","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD000030.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta3050","article-title":"Methods for evaluating area-wide and organisation-based intervention in health and health care: a systematic review","volume":"3","author":"Ukoumunne","year":"1999","journal-title":"Health Technology Assessment"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0920-9964(95)00013-C","article-title":"Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground","volume":"16","author":"Weinberger","year":"1995","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0061|cit61","volume-title":"International Classification of Disease and related disorders (ICD-10)","author":"World Health Organisation","year":"1992"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1192\/bjp.157.1.101","article-title":"Reduction in antipsychotic drug dosage in mentally handicapped patients; a hospital study","volume":"157","author":"Wressell","year":"1990","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000030.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1136\/jnnp.51.6.863","article-title":"Involuntary orofacial movements in hospitalised patients with mental handicap or epilepsy; relationship to developmental\/ intellectual deficit and presence or absence of long term exposure to neuroleptics","volume":"51","author":"Youseff","year":"1988","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD000030.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T11:28:20Z","timestamp":1723462100000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD000030.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Schizophrenia Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2004,10,18]]},"references-count":63,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,2]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd000030.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,10,18]]}}}